PRANDONI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.746
EU - Europa 1.777
AS - Asia 1.422
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 2
AF - Africa 1
Totale 20.965
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.729
CN - Cina 674
SG - Singapore 567
FI - Finlandia 442
SE - Svezia 267
UA - Ucraina 232
DE - Germania 227
FR - Francia 221
IT - Italia 178
VN - Vietnam 143
GB - Regno Unito 118
IE - Irlanda 37
BG - Bulgaria 21
CA - Canada 17
NL - Olanda 14
IN - India 13
JP - Giappone 10
RU - Federazione Russa 7
NZ - Nuova Zelanda 6
EU - Europa 5
HK - Hong Kong 5
AU - Australia 4
CZ - Repubblica Ceca 4
TR - Turchia 4
PL - Polonia 3
CH - Svizzera 2
GR - Grecia 2
PH - Filippine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EC - Ecuador 1
IQ - Iraq 1
IR - Iran 1
KR - Corea 1
NG - Nigeria 1
TH - Thailandia 1
Totale 20.965
Salva come PNG Salva come JPEG
Città #
Fairfield 3.243
Woodbridge 2.096
Houston 1.560
Ashburn 1.296
Seattle 1.213
Wilmington 1.194
Ann Arbor 1.184
Jacksonville 1.181
Cambridge 1.059
Chandler 816
Princeton 550
Singapore 400
San Diego 321
Nanjing 182
Roxbury 174
Des Moines 171
Medford 168
Dong Ket 141
Boardman 132
Helsinki 132
Beijing 103
Santa Clara 58
Shenyang 52
Nanchang 47
Hebei 42
Guangzhou 41
Jiaxing 41
Norwalk 37
London 35
New York 35
Dublin 34
Padova 33
Redwood City 33
Tianjin 31
Changsha 21
Sofia 21
Ogden 18
Kharkiv 16
Jinan 15
Kilburn 14
Washington 14
Mestre 12
Milan 12
Chicago 11
Borås 10
Shanghai 10
Indiana 9
Falls Church 8
Tsukuba 8
Los Angeles 7
Orange 7
Munich 6
Rockville 6
Altavilla Vicentina 5
Frankfurt am Main 5
Legnaro 5
Venice 5
Dallas 4
Lanzhou 4
Prineville 4
Québec 4
Rome 4
Suresnes 4
Yenibosna 4
Zhengzhou 4
Chiswick 3
Civitanova Marche 3
Easton 3
Hefei 3
Las Vegas 3
Leawood 3
Naples 3
Prescot 3
San Mateo 3
Saskatoon 3
Sheffield 3
Sydney 3
Taizhou 3
Tappahannock 3
Wandsworth 3
Amsterdam 2
Auckland 2
Belluno 2
Bologna 2
Bristol 2
Brno 2
Enterprise 2
Ferentino 2
Geislingen an der Steige 2
Geneva 2
Haikou 2
Ho Chi Minh City 2
Jaipur 2
Jesolo 2
Kansas City 2
Liverpool 2
Louisville 2
Marcon 2
Milton Keynes 2
Missoula 2
Totale 18.197
Salva come PNG Salva come JPEG
Nome #
Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease. 152
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score 151
A venous thromboembolism risk assessment model for patients with Cushing’s syndrome 127
The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort study 115
A Prospective Cohort Study On Patients Treated With Anticoagulants For Cerebral Vein Thrombosis. 110
How to effectively manage the event of bleeding complications when using anticoagulants 105
Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: data from the RIETE registry 101
The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation. 101
Fondaparinux in the initial and long-term treatment of venous thromboembolism 100
Long-term use of vitamin K antagonists and incidence of cancer: a population-based study 99
Unexpectedly high recanalization rate in patients with pulmonary embolism treated with anticoagulants alone. 99
Acute venous thromboembolism after non-major orthopaedic surgery or post-traumatic limb immobilisation 99
Thirty-day mortality rate in women with cancer and venous thromboembolism. Findings from the RIETE Registry 99
Aspirin for preventing the recurrence of venous thromboembolism. 98
Silent pulmonary embolism in patients with proximal deep vein thrombosis in the lower limbs 98
The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism 98
Antithrombotic Therapy for VTE Disease 97
Aspirin and recurrent venous thromboembolism in patients with symptomatic atherosclerosis: retrospective cohort study 96
Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism 96
A prospective study on cardiovascular events after acute pulmonary embolism. 95
Factor V Leiden is associated with more distal location of deep vein thrombosis of the leg. 95
Treatment of patients with acute deep vein thrombosis and/or pulmonary embolism: efficacy and safety of non-VKA oral anticoagulants in selected populations. 95
Thrombophilia and the risk of the post-thrombotic syndrome: retrospective cohort observation. 95
An unusual finding of massive pulmonary embolism in a patient during treatment with high-dose ibuprofen 95
The post-thrombotic syndrome 94
Cancer as a risk factor for stroke in atrial fibrillation patients receiving long-term oral anticoagulant therapy 94
Low reproducibility of the diagnosis of subsegmental pulmonary embolism in symptomatic patients 94
Iliopsoas bursitis and femoral vein thrombosis complicating total hip arthroplasty in an elderly patient 93
Cancer Screening in Unprovoked Venous Thromboembolism 93
Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. 92
The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: New scenarios and opportunities 92
Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study 92
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. 90
Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. 90
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. 89
Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism 88
Adherence to the novel oral anticoagulants: An unmet need 88
Use of prestudy heparin did not influence the efficacy and safety of rivaroxaban in patients treated for symptomatic venous thromboem-bolism in the EINSTEIN DVT and EINSTEIN PE studies 88
Family history of venous thrombosis or sudden death as a risk factor for venous thromboembolism. 87
Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis. 87
A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer. 87
Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study. 86
A prospective study on survival in cancer patients with and without venous thromboembolism 86
Approach to Venous Thromboembolism in the Cancer Patient 86
Accuracy of two newly described D-dimer tests in patients with suspected deep venous thrombosis. 86
Dabigatran antagonizes growth, cell-cycle progression, migration, and endothelial tube formation induced by thrombin in breast and glioblastoma cell lines 86
Thrombophilia as a predictor of persistent residual vein thrombosis 85
Risk factors, antithrombotic treatment and outcome in retinal vein occlusion: an age-related prospective cohort study 85
Factors Associated with elevated Pulmonary Arterial Pressure Levels on the Echocardiographic Assessment in Patients with Prior Pulmonary Embolism 85
D-Dimer testing as an adjunct to ultrasonography in patients with clinically suspected deep vein thrombosis: prospective cohort study. 84
Superficial vein thrombosis: Risk factors, diagnosis, and treatment 84
Treatment of venous thromboembolism: the single-drug approach 84
Superficial and deep venous thrombosis, pulmonary embolism and subsequent risk of cancer 84
Venous thromboembolism in 2013: The advent of the novel oral anticoagulants 84
Long-term therapy with low-molecular-weight heparin in cancer patients with venous thromboembolism 84
Unsuspected pulmonary embolism in patients with cancer 84
Screening for occult cancer in patients with idiopathic venous thromboembolism: Yes. 83
Thrombosis as a harbinger of cancer 83
“Thrombotic aura”: a case report 83
Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism 83
Venous thromboembolism as first manifestation of cancer. 82
Diagnosis of recurrent deep vein thrombosis. 82
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation. 82
Inherited thrombophilia and venous thromboembolism 82
Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis 82
An international survey on isolated subsegmental pulmonary embolism. 82
Pulmonary embolism: Epidemiology and registries 82
Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A/ORG31540) with pure anti-factor Xa activity. A phase II evaluation. 81
Cancer and venous thromboembolism. Clinical implications of a strong association 81
Cancer, thrombosis and heparin-induced thrombocytopenia 81
A simple ultrasound approach for detection of recurrent proximal-vein thrombosis. 81
Clinical presentation and outcome of venous thromboembolism in COPD 81
Physicians' compliance with the Padua Prediction Score for preventing venous thromboembolism among hospitalized medical patients. 81
The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: the Padua province experience 81
Venous thromboembolism in patients with intracranial haemorrhage 80
The risk of fetal loss in family members of probands with factor V Leiden 79
THE LONG TERM CLINICAL COURSE OF ACUTE DEEP VEIN THROMBOSIS OF THE ARM: PROSPECTIVE COHORT STUDY 79
Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism. 79
Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism. Findings from the RIETE Registry 79
Recurrent thromboembolism in fertile women with venous thrombosis: incidence and risk factors 79
Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism - an overview 79
Identifying high-risk individuals for cardiovascular disease: similarities between venous and arterial thrombosis in perspective. A 2011 update 79
Residual vein thrombosis and trans-popliteal reflux in patients with and without the post-thrombotic syndrome. 79
Cancer and venous thromboembolism 78
Healthcare burden associated with the post-thrombotic syndrome and potential impact of the new oral anticoagulants 78
Incidence of arterial embolism in patients on treatment with old and new anticoagulants for venous thromboembolism 78
Thrombophilia and the risk of post-thrombotic syndrome: Retrospective cohort observation 78
Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism. 77
Extended prophylaxis with bemiparin for prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study 77
Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. 77
The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study 77
The treatment of cancer-associated venous thromboembolism in the era of the novel oral anticoagulants 77
Comparison of four scores to predict major bleeding in patients receiving anticoagulation for venous thromboembolism: findings from the RIETE registry 77
Venous thromboembolism in immobilized patients with dementia. Findings from the RIETE registry. 77
Cancer and venous thromboembolism 76
Association between thrombophilia and the post-thrombotic syndrome: a systematic review and meta-analysis. 76
Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome 75
Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial 75
Heparin-associated thrombocytopenia in 24 401 patients with venous thromboembolism: findings from the RIETE Registry1 75
Oral Apixaban for the Treatment of Acute Venous Thromboembolism 75
Totale 8.815
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.590
article - articoli 67.720
book - libri 290
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 327
Totale 136.927
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.923 0 0 0 357 609 466 485 620 557 419 148 262
2020/20213.213 117 282 38 304 154 292 90 325 519 306 418 368
2021/20223.750 103 349 510 248 220 195 127 431 262 90 433 782
2022/20232.033 618 111 27 196 406 245 4 97 197 14 83 35
2023/20241.032 34 124 95 76 94 95 67 30 48 34 184 151
2024/2025710 17 299 260 134 0 0 0 0 0 0 0 0
Totale 21.101